Hamada Makiko, Ohtsuka Toshiaki, Kawaida Reimi, Koizumi Makoto, Morita Koji, Furukawa Hidehiko, Imanishi Takeshi, Miyagishi Makoto, Taira Kazunari
Biomedical Research Laboratories, Sankyo Co., Ltd., Tokyo 140-8710, Japan.
Antisense Nucleic Acid Drug Dev. 2002 Oct;12(5):301-9. doi: 10.1089/108729002761381285.
The highly specific posttranscriptional silencing of gene expression induced by double-stranded RNA (dsRNA) is known as RNA interference (RNAi) and has been demonstrated in plants, nematodes, Drosophila, and protozoa, as well as in mammalian cells. The suppression of expression of specific genes by chemically synthesized 21-nucleotide (21-nt) RNA duplexes has been achieved in various lines of mammalian cells, and this technique might prove to be a valuable tool in efforts to analyze biologic functions of genes in mammalian cells. In order to investigate the utility of potential modifications that can be introduced into small interfering RNAs (siRNAs) and also to study their functional anatomy, we synthesized different types of siRNA targeted to mRNA of Jun dimerization protein 2 (JDP2). Our detailed analysis demonstrated that siRNAs with only one mismatch, relative to the target, on the antisense strand had reduced RNAi effect, whereas the corresponding mutation on the sense strand did not interfere with the RNAi. Moreover, one 2-hydroxyethylphosphate (hp) substitution at the 3'-end of the antisense strand but not of the sense strand also prevented RNAi, whereas a related modification at the 3'-end of either strand, using 2'-O,4'-C-ethylene thymidine (eT), which is a component of ethylene-bridge nucleic acids (ENA), completely abolished RNAi. These results support the hypothesis that the two strands have different functions in RNAi in cultured mammalian cells and indicate that their chemical modification of siRNAs at the 3'-end of the sense strand exclusively is possible, without loss of RNAi activity, depending on the type of modification. Because modification at the 3'-end of the antisense strand by hp or eT abolished the RNAi effect, it appears possible that the 3'-end is recognized by the RNA-induced silencing complex (RISC).
双链RNA(dsRNA)诱导的基因表达的高度特异性转录后沉默被称为RNA干扰(RNAi),已在植物、线虫、果蝇、原生动物以及哺乳动物细胞中得到证实。通过化学合成的21核苷酸(21-nt)RNA双链体抑制特定基因的表达已在多种哺乳动物细胞系中实现,这项技术可能成为分析哺乳动物细胞中基因生物学功能的一项有价值的工具。为了研究可引入小干扰RNA(siRNA)的潜在修饰的效用,并研究它们的功能结构,我们合成了针对Jun二聚化蛋白2(JDP2)mRNA的不同类型的siRNA。我们的详细分析表明,相对于靶标,反义链上仅有一个错配的siRNA的RNAi效应降低,而正义链上的相应突变并不干扰RNAi。此外,反义链而非正义链的3'端的一个2-羟乙基磷酸酯(hp)取代也阻止了RNAi,而使用作为乙烯桥核酸(ENA)组分的2'-O,4'-C-乙烯胸苷(eT)对任何一条链的3'端进行相关修饰则完全消除了RNAi。这些结果支持了这样的假说,即在培养的哺乳动物细胞的RNAi中两条链具有不同功能,并表明根据修饰类型,仅对正义链的3'端进行siRNA的化学修饰是可能的,且不会丧失RNAi活性。由于通过hp或eT对反义链的3'端进行修饰消除了RNAi效应,因此3'端似乎有可能被RNA诱导沉默复合体(RISC)识别。